CM
ELV icon

Crestline Management’s Elevance Health ELV Stock Holding History

Crestline Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,966
Closed -$1.09M – 196
2024
Q4 		$1.09M Buy
2,966
+1,704
+135% +$713K 0.04% 393
2024
Q3 		$656K Buy
+1,262
New +$674K 0.03% 333
2022
Q1 		– Sell
-30,000
Closed -$13.9M – 278
2021
Q4 		$13.9M Buy
+30,000
New +$12.6M 1.04% 13
2021
Q1 		– Sell
-50,000
Closed -$16.1M – 115
2020
Q4 		$16.1M Buy
+50,000
New +$15.3M 1.7% 11
2020
Q1 		– Sell
-37,000
Closed -$11.2M – 49
2019
Q4 		$11.2M Buy
+37,000
New +$10.2M 1.45% 18

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Crestline Management's ELV Position: Q1 2025 in Review

Crestline Management sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 2,966 shares — an estimated $1.09M sold.

Crestline Management first reported a position in ELV in Q4 2019 and held it in 5 quarters. The position peaked at $16.1M in Q4 2020. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Crestline Management reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 2,966 Elevance Health shares in Q1 2025, an estimated $1.09M.
  • Crestline Management first reported a position in Elevance Health in Q4 2019 and held it in 5 quarters.
  • Crestline Management's Elevance Health position peaked at $16.1M in Q4 2020.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.